Replies to post #20123 on RespireRx Pharmaceuticals Inc (fka RSPI)

[eitzen]

One correction:

"To say the market cap at that point could be a billion ($10/share) with a PARTNERSHIP (rather than deal as originally written) done, but revenue way off is not realistic in my view.

[haysaw]

<<I'm not nearly as negative on Dr. Stoll as most of the posters here. However, with a new man at the helm, it's an unknown.>>

Two points on this:

1)Most on this board are pro-Stoll, or at least not vocal about his negatives. I understand the possible reasoning: What good does it do?

2)I don't think Varney is much of an unknown. The consensus here, I believe, is that his style will mimic Stoll's. IMO, it is like McCain succeeding Bush. In that case, the risk is the 'known,' not unknown. Let's just hope luck or synchronicity of some sort play out to make the conclusion to the Cortex saga a good one.